Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.58 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | EP300 | Q09472 | 1/20 | 0.50 |
| ▸ | TERT | O14746 | 3/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | PPARD | Q03181 | 3/20 | 0.48 |
| ▸ | PPARA | Q07869 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2089326 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3614627 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL230508 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL252542 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL4081081 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL252540 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL230509 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL484136 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL484135 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3389917 | 1.00 | FAAH (0.58) | FAAHSOAT1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986187-A | Compound and acrylamide polymer with oil displacement effect as well as preparation methods and applications thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117945955-A | Compound, polymer with tackifying and emulsifying functions, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023222004-A1 | FREE RADICAL SOLUTION POLYMERIZATION METHOD, POLYMER, AND USE | 中国石油化工股份有限公司 | 2023-11-23 | — | — | WO | disclosed |
| US-7500895-B2 | Patterned substrate, electro-optical device, and method for manufacturing an electro-optical device | SEIKO EPSON CORPORATION (JP) | 2009-03-10 | — | — | US | disclosed |
| US-20060127563-A1 | Patterned substrate, electro-optical device, and method for manufacturing an electro-optical device | SEIKO EPSON CORPORATION (JP) | 2006-06-15 | — | — | US | disclosed |
| US-7048917-B1 | Fat-binding polymers | GENZYME CORPORATION (US) | 2006-05-23 | — | — | US | disclosed |
| US-20050287392-A1 | Organic electroluminescent device, method for producing the same, and electronic apparatus | SEIKO EPSON CORPORATION (JP) | 2005-12-29 | — | — | US | disclosed |
| US-6726906-B1 | ORALLY ADMINISTERED POLY(N,N-DI(2,3-DIHYDROXYPROPYL) ALLYLAMINE)HYDROCHLORIDE AND TETRAHYDROLIPSTATIN LIPASE INHIBITOR; HYPERTRIGLYCERIDEMIA; SIDE EFFECT REDUCTION | GENZYME CORPORATION | 2004-04-27 | — | — | US | disclosed |
| EP-1196181-A1 | FAT-BINDING POLYMERS, OPTIONALLY COMBINED WITH LIPASE INHIBITORS | Geltex Pharmaceuticals, Inc. (US) | 2002-04-17 | — | — | EP | disclosed |
| US-6299868-B1 | FACILITATES THE REMOVAL OF FAT FROM THE BODY PRIOR TO DIGESTION, WITH MINIMAL SIDE EFFECTS AND LOW TOXICITY; FOR THERAPY OF OBESITY, STEATORRHEA, HYPERTRIGLYCERIDEMIA IN MAMMALS | GELTEX PHARMACEUTICALS, INC. | 2001-10-09 | — | — | US | disclosed |
| WO-2001005408-A1 | FAT-BINDING POLYMERS, OPTIONALLY COMBINED WITH LIPASE INHIBITORS | GELTEX PHARMACEUTICALS, INC. (US) | 2001-01-25 | — | — | WO | disclosed |